CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients

Stopped The study closed per PI decision due to completion of the biopsy substudy and slow accrual

Conditions

• Kidney Transplant; Complications
• Diabetes Mellitus, Type 2

Interventions

• DRUG: Empagliflozin10Mg Tab
• DRUG: Placebo

Sponsor

Duke University